Arthur Kirsch
Director/Board Member at LIQUIDIA CORPORATION
Net worth: 673 860 $ as of 30/05/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Seth A. Rudnick | M | 75 |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 16 years |
| Stephen Bloch | M | 62 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 15 years |
| Damian deGoa | M | 45 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 4 years |
| Joanna Horobin | M | 69 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 5 years |
| Michael Kaseta | M | 48 | 8 years | |
| Raman Singh | M | 53 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 4 years |
| Katherine Rielly-Gauvin | F | 61 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 5 years |
| Roger Jeffs | M | 62 | 4 years | |
| Minh Duong | M | - |
Anavasi Diagnostics
| 4 years |
| Robert Atkinson | M | - |
Anavasi Diagnostics
| 4 years |
| Barry Lutz | M | - |
Anavasi Diagnostics
| 4 years |
| Robert Lippe | M | 59 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 9 years |
| Pat Atkinson | M | - |
Anavasi Diagnostics
| - |
| Nelson Patterson | M | - |
Anavasi Diagnostics
| 4 years |
| Steven Bariahtaris | M | 60 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 4 years |
| David Johnson | M | 41 | 3 years | |
| Russell Schundler | M | 49 | 3 years | |
| Tushar Shah | M | 64 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 4 years |
| Paul Manning | M | 68 | 4 years | |
| Debra Patterson | M | - |
Anavasi Diagnostics
| - |
| Scott Moomaw | M | 54 | 4 years | |
| Florina Gordon-Krawchick | F | 42 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 14 years |
| Jason Adair | M | - |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 8 years |
| David Vied | M | 63 |
Anavasi Diagnostics
| 2 years |
| Guy Ellis | M | - |
Anavasi Diagnostics
| 3 years |
| Rajeev Saggar | M | 50 | 2 years | |
| Bryan Crane | M | - |
Anavasi Diagnostics
| 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Eric Trachtenberg | M | 51 | 3 years | |
| Neal Fowler | M | 62 | 9 years | |
| Steven N. Gordon | M | 56 | 10 years | |
| Adrian Adams | M | 73 | 4 years | |
| Jennifer Lou Armstrong-Owen | F | 54 | 4 years | |
| John R. Plachetka | M | 70 | 19 years | |
| Kenneth Lee | M | 76 | 14 years | |
| Philip Friedman | M | - |
Drexel Burnham Lambert, Inc.
| 8 years |
| Ralph Snyderman | M | 84 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | - |
| Michael R. Garone | M | 66 | 3 years | |
| John Sorte | M | 77 |
Drexel Burnham Lambert, Inc.
| 12 years |
| Scott J. Charles | M | 49 | 2 years | |
| Dixon Boardman | M | - | 10 years | |
| James Tursi | M | 59 | 3 years | |
| Gilda Marie Thomas | F | 69 | 8 years | |
| Mark Glickman | M | 58 | 3 years | |
| D. Theodore Berghorst | M | - |
Vector Securities LLC
 Vector Securities LLC Investment Banks/BrokersFinance Part of Prudential Financial, Inc., Vector Securities LLC is a company that provides investment banking services. The company is based in Deerfield, IL. Vector Securities was acquired by Prudential Securities on June 09, 1999. | - |
| Isaac Cheng | M | 49 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 8 years |
| Nichol Ochsner | M | - | 3 years | |
| Leon Black | M | 73 |
Drexel Burnham Lambert, Inc.
| 13 years |
| Richard D. Katz | M | 60 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 1 years |
| Dick L. Sherman | M | 76 | 2 years | |
| Ed Mathers Mathers | M | 64 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 10 years |
| Everardus Orlemans | M | 67 | 5 years | |
| Alf Gunnar Martin Nicklasson | M | 69 | 3 years | |
| Michael King | M | 63 |
Vector Securities LLC
Vector Securities LLC Investment Banks/BrokersFinance Part of Prudential Financial, Inc., Vector Securities LLC is a company that provides investment banking services. The company is based in Deerfield, IL. Vector Securities was acquired by Prudential Securities on June 09, 1999. | 1 years |
| Jason Aryeh | M | 55 | 1 years | |
| James Joseph Mauzey | M | 75 | 6 years | |
| John G. Fort | M | 69 | - | |
| Jason Rushton | M | 54 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | - |
| William Ostrander | M | 56 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 5 years |
| Christopher Freeland | M | 45 | 3 years | |
| Andrew Koven | M | 66 | 4 years | |
| Kevin Gordon | M | 61 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 1 years |
| William L. Hodges | M | 69 | 12 years | |
| Sanjay Subramanian | M | 48 | 4 years | |
| Timothy M. Albury | M | 55 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | 6 years |
| Francis Thrasher | M | 73 | 3 years | |
| Jonathan Sokoloff | M | 66 |
Drexel Burnham Lambert, Inc.
| - |
| Jeri Thomas | F | 63 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | - |
| William David Fertig | M | 67 |
Drexel Burnham Lambert, Inc.
| 1 years |
| Nancy Miller-Rich | F | 65 | 1 years | |
| A. Levison | M | 67 |
Drexel Burnham Lambert, Inc.
| 4 years |
| Susan Wiviott | F | 66 | 9 years | |
| Peter J. Wise | M | 89 | - | |
| Michael Jack Kugler | M | 83 |
Drexel Burnham Lambert, Inc.
| 8 years |
| Marshal Kerry McReal | M | - |
Drexel Burnham Lambert, Inc.
| - |
| Lisa Carnoy | F | 56 |
Drexel Burnham Lambert, Inc.
| 1 years |
| P. David Otterbach | M | 64 |
Drexel Burnham Lambert, Inc.
| 12 years |
| Tom Prunty | M | - |
Drexel Burnham Lambert, Inc.
| - |
| W. Baxter | M | - |
Drexel Burnham Lambert, Inc.
| 6 years |
| Ronald J. Manganiello | M | - |
Drexel Burnham Lambert, Inc.
| 7 years |
| John Walsh | M | - |
Drexel Burnham Lambert, Inc.
| - |
| George Patrice Fraise | M | 60 |
Drexel Burnham Lambert, Inc.
| 12 years |
| Paul Levy | M | 76 |
Drexel Burnham Lambert, Inc.
| - |
| Philip Roger Howard Connor | M | - |
Drexel Burnham Lambert, Inc.
| - |
| Paul J. Rizzo | M | 96 | 8 years | |
| Michael Gross | M | 62 |
Drexel Burnham Lambert, Inc.
| 3 years |
| Ted G. Wood | M | 86 | 6 years | |
| Stelios Papadopoulos | M | 75 |
Drexel Burnham Lambert, Inc.
| - |
| James L. Rawlings | M | 79 |
Drexel Burnham Lambert, Inc.
| 9 years |
| Bruce A. Tomason | M | 76 | 11 years | |
| Mike G. Mayfield | M | - |
Drexel Burnham Lambert, Inc.
| 10 years |
| Carol Goering Frankenfield | F | - |
Drexel Burnham Lambert, Inc.
| 2 years |
| Tim Tarpening | M | - |
Drexel Burnham Lambert, Inc.
| - |
| Kenneth Bobby Turner | M | - |
Drexel Burnham Lambert, Inc.
| - |
| David Schachter | M | 70 |
Drexel Burnham Lambert, Inc.
| 10 years |
| John Anthony Idone | M | - |
Drexel Burnham Lambert, Inc.
| 6 years |
| David Adams Taft | M | 67 |
Drexel Burnham Lambert, Inc.
| 5 years |
| Thomas Pritchard | M | 62 |
Drexel Burnham Lambert, Inc.
| - |
| Richard Williams | M | 63 |
Drexel Burnham Lambert, Inc.
| - |
| Randy F. Rock | M | 72 |
Drexel Burnham Lambert, Inc.
| - |
| Chien Huang | M | - | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 94 | 94.00% |
| Canada | 17 | 17.00% |
| United Kingdom | 0 | -.--% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Arthur Kirsch
- Personal Network
